Dyadic International (DYAI) Q2 2026 Earnings Call: Commercial Progress and Liquidity RiskTradingKey·Aug 14 at 03:16 AMDYAI-5.26%
Dyadic International prices unregistered warrant private placement at $0.005 per warrantPUBT·Aug 13 at 07:03 AMDYAI-5.26%
Dyadic International Warns of Going-Concern Risk as Dilution, Nasdaq Uncertainty and Noteholder Dependence Threaten Shareholder ValueTip Ranks·Aug 13 at 01:00 AMDYAI-5.26%
Dyadic net loss widens 18.8% to USD 2.12 million in Q2 FY26; revenue slips 0.6% to USD 961,138PUBT·Aug 12 at 07:34 AMDYAI-5.26%
Dyadic Announces Second Quarter 2026 Financial Results Accelerating Commercialization Momentum Across Key Business AreasUnusual Whales·Aug 12 at 07:31 AMDYAI-5.26%
Dyadic signs development, commercial license deal with European biotech for precision-fermented dairy proteinsPUBT·Aug 4 at 06:25 AMDYAI-5.26%
Dyadic Expands Commercial Non-Animal Dairy Pipeline Through New Strategic Development Agreement | DYAI Stock NewsStockTitan·Aug 3 at 10:25 PMDYAI-5.26%
Dyadic International updates financial calendar, sets Q2 results release and conference callPUBT·Aug 3 at 03:39 PMDYAI-5.26%
Francisco Trust trustee Thomas Emalfarb sells 95,392 Dyadic International common shares worth $124,823.82PUBT·Jul 24 at 04:12 PMDYAI-5.26%
Dyadic Announces Continued Listing on the Nasdaq Capital Market | DYAI Stock NewsStockTitan·Jul 23 at 10:30 PMDYAI-5.26%
